Blumer v. ACU-GEN BIOLABS, INC.

638 F. Supp. 2d 81, 2009 U.S. Dist. LEXIS 65339, 2009 WL 2251426
CourtDistrict Court, D. Massachusetts
DecidedJuly 28, 2009
DocketCivil Action 06-10359-RCL
StatusPublished

This text of 638 F. Supp. 2d 81 (Blumer v. ACU-GEN BIOLABS, INC.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Blumer v. ACU-GEN BIOLABS, INC., 638 F. Supp. 2d 81, 2009 U.S. Dist. LEXIS 65339, 2009 WL 2251426 (D. Mass. 2009).

Opinion

MEMORANDUM AND ORDER

YOUNG, District Judge.

I. INTRODUCTION

This putative class action arises from the sales and marketing of the Baby Gender Mentor Kit (“Gender Mentor”), a product which purportedly detects the gender of a fetus through genetic analysis of maternal blood samples. Chang-Ning Wang (“Wang”) is the owner and President of Acu-Gen Biolabs, Inc. (“AcuGen”), a Massachusetts corporation that manufactures, markets and sells the Gender Mentor. Sherry Bonelli (“Bonelli”) is the owner, and President of the Pregnancy Store and Pregnancystore.com, Illinois entities which also distribute the Gender Mentor. The Plaintiffs allege that AcuGen, Wang, Bonelli, Pregnancy Store, and Pregnancystore.com (together, the “Defendants”) falsely promoted the Gender Mentor product as being 99% accurate, caused customers consequential damages averaging $1000 per customer, inflicted emotional distress, and failed upon request to provide customers with the 200% refund guarantee. The Plaintiffs move to further amend their already twice amended complaint to supplement the alleged facts and add additional named plaintiffs. On the basis of the third amended complaint, Acu-Gen and Wang oppose the motion to amend as futile, failing to cure jurisdictional deficiencies.

II. FACTUAL BACKGROUND AND PROCEDURAL HISTORY 1

The Gender Mentor container includes a directional insert, two pregnancy tests, a *84 specimen collection kit, and a shipping envelope. (Third. Am. Compl. ¶42.) The Gender Mentor retails for $25.00, not including tax, shipping and handling charges. Id. at ¶ 42. Once complete, the kits are to be mailed, at consumer’s expense, to Acu-Gen, where the cost of the lab testing and processing is $250.00. Id. at ¶ 42. The Gender Mentor is sold online exclusively through the unow.babygender mmtor.com and www.pregnancystore.com websites. Id. at ¶ 44. As of December 8, 2008, the Defendants have sold approximately 6,521 Gender Mentor units. Id. at ¶ 33.

The Defendants advertise that the product can discern the gender of the fetus by detecting gender specific fetus genetic materials in the maternal blood, “offering] the most accurate and the earliest baby gender test to date.” (Third. Am. Compl. ¶ 43.) The Defendants’ websites advertise and market the product as being “99.9% accurate” and “infallibly accurate in foretelling the gender of a healthy baby.” Id. at ¶ 41. The websites “guarantee that all test results will be absolutely 99.9% accurate.” Id. Both websites contain statements that guarantee customers will be entitled to a 200% refund if the results are not correct. Id. at ¶ 44. 2 According to its own submission, Acu-Gen has paid refunds to 565 purchasers as of December 8, 2008. (Defendants Acu-Gen and Wang’s Memorandum of Law in Support of Their Opposition to the Plaintiffs’ Motion to Amend [“Defs.’ Opp.”] 3.) The Plaintiffs maintain that the majority of these refunds were paid after the initial filing of the class action.

The Plaintiffs claim that the Defendants intentionally misrepresent the Gender Mentor’s scientific accuracy. (Third Am. Compl. ¶ 45.) The Plaintiffs allege that when women with incorrect test results attempt to obtain their refund, the Defendants refused to abide by the guarantee. Id. at ¶ 48. When questioned by women about the inaccuracy of test results, Wang allegedly gave myriad reasons including chromosomal abnormalities in the fetus, vanishing twin syndrome 3 , and infant deformities. Id. at ¶ 49. Based on Wang’s statements, the Plaintiffs allege that women feared for their babies’ health and undertook unnecessary and dangerous procedures, including multiple ultrasounds, amniocentesis, and chromosomal testing. Id. Many of these tests were not covered by the women’s medical insurance, in which case, they paid for the procedures themselves. Id.

One hundred thirteen named plaintiffs filed a Second Amended Complaint against the Defendants on October 26, 2006. (Docket No. 43.) The parties engaged in unsuccessful settlement negotiations. On October 16, 2008, Acu-Gen and Wang filed a motion to dismiss the Plaintiffs’ Second Amended Complaint for lack of jurisdiction. (Docket No. 77.) Thereafter, the Plaintiffs filed a motion for summary judgment as to liability on November 21, 2008. (Docket No. 85.) The Court heard oral arguments on the motion to dismiss on December 9, 2008 and ruled further juris *85 dictional discovery pertinent. The Court ordered both parties to proceed with the summary judgment schedule and heard both the motion to dismiss and summary judgment oral arguments on January 22, 2009. The Court granted the Defendant’s motion to dismiss for lack of jurisdiction without prejudice, thus mooting the Plaintiffs’ motion for summary judgment (Docket No. 85).

On February 19, 2009, the Plaintiffs filed a motion to amend their complaint and attached a Third Amended Complaint with 198 named plaintiffs. The Plaintiffs allege this Court has subject-matter jurisdiction under the Class Action Fairness Act (“CAFA”), 28 U.S.C. §§ 1332(d), 1453 and the Magnuson-Moss Warranty-Federal Trade Commission Improvement Act (“Magnuson-Moss Act”), 15 U.S.C. § 2310(d)(3). The proposed Third Amended Complaint alleges eight counts: unjust enrichment; U.C.C. §§ 2-313, 2-314 and 2-315 violations; civil conspiracy; negligence; negligent misrepresentation; and violations of 15 U.S.C. § 2301 (the Magnuson-Moss Act) and Chapter 93A of the General Laws of Massachusetts.

III. ANALYSIS

A. Motion to Amend
1. Applicable Standard of Review

The Court should “freely give leave [for amendments] when justice so requires.” Fed.R.Civ.P. 15(a)(2). District courts enjoy “significant latitude in deciding whether to grant leave to amend.” U.S. ex rel. Gagne v. City of Worcester, 565 F.3d 40, 48 (1st Cir.2009) (quoting ACA Fin. Guar. Coup. v. Advest, Inc., 512 F.3d 46, 55 (1st Cir.2008)) (internal citation omitted). Courts appropriately may deny leave for several reasons including “undue delay in filing the motion, bad faith or dilatory motive, repeated failure to cure deficiencies, undue prejudice to the opposing party, and futility of amendment.” Id. “In assessing futility, the district court must apply the standard which applies to motions to dismiss under Fed.R.Civ.P. 12(b)(6).” Adorno v. Crowley Towing And Transp.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell v. Hood
327 U.S. 678 (Supreme Court, 1946)
Resolution Trust Corp. v. Gold
30 F.3d 251 (First Circuit, 1994)
Barrett v. Veritas Offshore
239 F.3d 23 (First Circuit, 2001)
Adorno v. Crowley Towing & Transportation Co.
443 F.3d 122 (First Circuit, 2006)
Amoche v. Guarantee Trust Life Insurance
556 F.3d 41 (First Circuit, 2009)
United States Ex Rel. Gagne v. City of Worcester
565 F.3d 40 (First Circuit, 2009)
Margaret Austin, Etc. v. Unarco Industries, Inc.
705 F.2d 1 (First Circuit, 1983)
John F. "Jack" Walsh v. Ford Motor Company
807 F.2d 1000 (D.C. Circuit, 1986)
Walsh v. Ford Motor Co.
588 F. Supp. 1513 (District of Columbia, 1984)
Massachusetts Eye and Ear Infirmary v. QLT, INC.
495 F. Supp. 2d 188 (D. Massachusetts, 2007)
Galicia v. Country Coach, Inc.
324 F. App'x 687 (Ninth Circuit, 2009)
Abraham v. Volkswagen of America, Inc.
795 F.2d 238 (Second Circuit, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
638 F. Supp. 2d 81, 2009 U.S. Dist. LEXIS 65339, 2009 WL 2251426, Counsel Stack Legal Research, https://law.counselstack.com/opinion/blumer-v-acu-gen-biolabs-inc-mad-2009.